Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial

四分位间距 心房颤动 医学 临床终点 置信区间 随机对照试验 内科学 优势比 心脏病学
作者
Konstantinos D. Rizas,Luisa Freyer,Nikolay Sappler,Lukas von Stülpnagel,Peter Spielbichler,Aresa Krasniqi,Michael Schreinlechner,Felix N. Wenner,Fabian Theurl,Amira Behroz,Elodie Eiffener,Mathias Klemm,Annika Schneidewind,Martin Zens,Theresa Dolejsi,Ulrich Mansmann,Steffen Maßberg,Axel Bauer
出处
期刊:Nature Medicine [Nature Portfolio]
卷期号:28 (9): 1823-1830 被引量:131
标识
DOI:10.1038/s41591-022-01979-w
摘要

Digital smart devices have the capability of detecting atrial fibrillation (AF), but the efficacy of this type of digital screening has not been directly compared to usual care for detection of treatment-relevant AF. In the eBRAVE-AF trial (NCT04250220), we randomly assigned 5,551 policyholders of a German health insurance company who were free of AF at baseline (age 65 years (median; interquartile range (11) years, 31% females)) to digital screening (n = 2,860) or usual care (n = 2,691). In this siteless trial, for digital screening, participants used a certified app on their own smartphones to screen for irregularities in their pulse waves. Abnormal findings were evaluated by 14-day external electrocardiogram (ECG) loop recorders. The primary endpoint was newly diagnosed AF within 6 months treated with oral anti-coagulation by an independent physician not involved in the study. After 6 months, participants were invited to cross-over for a second study phase with reverse assignment for secondary analyses. The primary endpoint of the trial was met, as digital screening more than doubled the detection rate of treatment-relevant AF in both phases of the trial, with odds ratios of 2.12 (95% confidence interval (CI), 1.19–3.76; P = 0.010) and 2.75 (95% CI, 1.42–5.34; P = 0.003) in the first and second phases, respectively. This digital screening technology provides substantial benefits in detecting AF compared to usual care and has the potential for broad applicability due to its wide availability on ordinary smartphones. Future studies are needed to test whether digital screening for AF leads to better treatment outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hgy完成签到 ,获得积分20
刚刚
刚刚
wumumu发布了新的文献求助30
1秒前
1秒前
1秒前
蔡蔡蔡完成签到 ,获得积分10
1秒前
zhangruidan完成签到 ,获得积分20
2秒前
2秒前
xiaoxuey发布了新的文献求助10
2秒前
SSSSCCCCIIII完成签到,获得积分10
3秒前
4秒前
激动的手链完成签到,获得积分20
4秒前
vc发布了新的文献求助10
4秒前
zs发布了新的文献求助30
6秒前
molihuakai的应助被猜猜我是谁采纳,获得10
6秒前
6秒前
乾y完成签到 ,获得积分10
7秒前
bone发布了新的文献求助10
7秒前
Orange的应助被科研大印采纳,获得10
7秒前
8秒前
8秒前
6zz发布了新的文献求助20
9秒前
10秒前
10秒前
Akim的应助被wumumu采纳,获得10
10秒前
爆米花的应助被感动的易真采纳,获得10
10秒前
lcj发布了新的文献求助20
11秒前
11秒前
11秒前
天佑完成签到,获得积分10
11秒前
Orange的应助被科研小少年采纳,获得10
11秒前
12秒前
黄某发布了新的文献求助10
13秒前
zzzzzz发布了新的文献求助10
13秒前
hin发布了新的文献求助10
14秒前
鼻毛好胜完成签到,获得积分10
15秒前
15秒前
soda发布了新的文献求助10
15秒前
JamesPei的应助被WenjingziWang采纳,获得10
15秒前
充电宝的应助被3123939715采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178866
求助须知:如何正确求助?哪些是违规求助? 9569638
关于积分的说明 21805411
捐赠科研通 7774048
什么是DOI,文献DOI怎么找? 3432955
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478628